Definium Therapeutics, Inc.
DFTX
$42.63
-$1.27-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -158.99M | -77.10M | -50.44M | -67.27M | -42.74M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.92M | 29.02M | 11.75M | 29.60M | 5.06M |
| Change in Net Operating Assets | 6.28M | 5.45M | -4.29M | 8.10M | 8.09M |
| Cash from Operations | -52.78M | -42.63M | -42.98M | -29.57M | -29.60M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -316.74M | 42.00M | 34.98M | 15.41M | -39.54M |
| Cash from Investing | -316.74M | 42.00M | 34.98M | 15.41M | -39.54M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 42.00M |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -22.00M |
| Issuance of Common Stock | 808.68M | 5.31M | 261.81M | 749.00K | 97.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.42M | -- | -15.95M | 0.00 | -447.00K |
| Cash from Financing | 762.27M | 5.31M | 245.87M | 749.00K | 19.65M |
| Foreign Exchange rate Adjustments | -1.00K | 3.00K | 1.00K | -21.00K | 25.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 392.75M | 4.68M | 237.88M | -13.43M | -49.46M |